GVHD
Advertisement
The study highlighted that adding abatacept to CNI/MTX-based GVHD prophylaxis showed durable central outcomes post-HCT.
Kirk R. Schultz, MD, FCAHS, explains that multiple strategies for GVHD prevention and preemption are under investigation.
Risk factors for GVHD and its severity differ by donor type following allogeneic SCT with post-transplant PTCy prophylaxis.
Patients with pulmonary comorbidities and a history of smoking are at increased risk for chronic GVHD.
Piyanuch Kongtim, MD, PhD, shares insights from work she presented at the 2024 ASH Annual Meeting.
Irwin Walker, MBBS, joined Cancer Nursing Today at ASH 2024 to share his insights on the pilot trial and the next steps.
Patient-reported outcomes increased the risk of health care utilization and HCT-related complications, like GVHD, post HCT.
Chronic GVHD is less frequent in children than in adults, but its frequency has come down much more significantly in adults.
Noah Merin, MD, PhD, explains how the GVHD prophylaxis method has changed outcomes and shares nursing implications at ASH.
The study, presented at ASH 2024, showed that none of the patients experienced grade 3-4 GVHD.
Metabolite profiles may be promising as predictive biomarkers for clinical outcomes in patients post-HSCT at risk of GVHD.
A study presented at ASH evaluated GVHD and NRM outcomes in patients who received allogeneic transplant after CAR-T.
Research presented at ASH showed that baseline fatigue and depression were associated with acute GVHD.
Orca-Q showed promising efficacy, safety, and low GVHD rates in patients with high-risk hematologic malignancies.
Research presented at ASH 2024 provides novel insights into GVHD pathogenesis and potential therapeutic strategies.
They developed and validated day 28 refined response criteria for first-and second-line treatment in grades II-IV acute GVHD.
Oncology nurses need to understand this complication to identify patients at high risk for steroid-induced hyperglycemia.
A researcher who will present on patient-reported outcomes and GVHD outcomes discusses the importance of the meeting.
Learn what researchers found about the real-world use of belumosudil as a treatment for chronic GVHD.
A new study is highlighting the importance of fiber intake after allogeneic transplantation.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.